BIOMARIN PHARMACEUTICAL INC Annual Income Tax Expense (Benefit) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Biomarin Pharmaceutical Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
  • Biomarin Pharmaceutical Inc Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $25M, a 69% increase year-over-year.
  • Biomarin Pharmaceutical Inc Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $42.1M, a 419% increase year-over-year.
  • Biomarin Pharmaceutical Inc annual Income Tax Expense (Benefit) for 2023 was $20.9M, a 161% increase from 2022.
  • Biomarin Pharmaceutical Inc annual Income Tax Expense (Benefit) for 2022 was $8.02M.
  • Biomarin Pharmaceutical Inc annual Income Tax Expense (Benefit) for 2021 was -$11.3M, a 98.8% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $20.9M +$12.9M +161% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-26
2022 $8.02M +$19.3M Jan 1, 2022 Dec 31, 2022 10-K 2024-02-26
2021 -$11.3M +$892M +98.8% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 -$903M -$832M -1173% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 -$71M -$5.47M -8.35% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
2018 -$65.5M -$147M -181% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 $81.2M +$282M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 -$201M -$218M -1276% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $17.1M +$7.97M +87.6% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-26
2014 $9.1M +$9.25M Jan 1, 2014 Dec 31, 2014 10-K 2017-02-27
2013 -$150K +$3.78M +96.2% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
2012 -$3.93M -$14.1M -139% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-02
2011 $10.2M +$238M Jan 1, 2011 Dec 31, 2011 10-K 2014-02-26
2010 -$227M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.